357: The upheaval of CDC's vaccine panel, and drug pricing confusion
12 Jun 2025
45m
STAT · Science
The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
356: An AI experiment at the FDA & Novo trailing in the obesity drug race
05 Jun 2025
33m
355: Moderna’s vaccine hit, the MAHA report, and an ASCO preview
29 May 2025
36m
354: Uncertainty in CRISPR world and the start of more M&A
22 May 2025
41m
353: Trump's drug-pricing plan and a potential Theranos 2.0
15 May 2025
25m
352: A firebrand takes oversight of vaccines, gene therapies
08 May 2025
26m
351: It's gonna be May (in biotech)
01 May 2025
34m
350: Pharma tariffs, and a 'sunshine day' for biotech stocks
24 Apr 2025
30m
349: BIO's John Crowley on RFK Jr. and tariffs, plus calls for more federal biotech funding
10 Apr 2025
40m
348: Cuts, ousters and drama at the FDA
03 Apr 2025
31m
347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival
27 Mar 2025
31m
346: Zealand's obesity strategy and Immunovant's curious development plan
20 Mar 2025
42m
345: The sudden withdrawal of a CDC nominee and what went wrong with Covid policies
13 Mar 2025
31m
344: Trump's FDA commissioner nominee takes the hot seat
06 Mar 2025
25m
343: Turbulence at the FDA, Bluebird Bio's sale and young biotech VCs
27 Feb 2025
32m
342: FDA cuts, zombie biotechs, and too much weight loss?
20 Feb 2025
41m
341: NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers
13 Feb 2025
26m
340: Crisis in CRISPR world, RFK Jr.'s promises, and a novel non-opioid pain drug
06 Feb 2025
34m
339: RFK Jr.'s confirmation hearings, MASH drugs, and a controversial obesity ad
30 Jan 2025
34m
338: Chinese biotechs, a WHO departure, and post-JPM thoughts
23 Jan 2025
33m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.